Next Advances in Lung Cancer Target MET, KRAS Next Advances in Lung Cancer Target MET, KRAS

Although this past ASCO meeting may have lacked drama and excitement, Mark Kris was encouraged by studies on new targets and new drug constructs in lung cancer.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Related Links:

Publication date: December 2019Source: Materials Science and Engineering: C, Volume 105Author(s): Sushma Havanur, Inayat Batish, Sri Pragnya Cheruku, Karthik Gourishetti, JagadeeshBabu P.E., Nitesh KumarAbstractCancer has emanated as a daunting menace to human-kind even though medicine, science, and technology has reached its zenith. Subsequent scarcity in the revelation of new drugs, the exigency of salvaging formerly discovered toxic drugs such as doxorubicin has emerged. The invention of drug carrier has made drug delivery imminent which is ascribable to its characteristic traits of specific targeting, effective respons...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
Publication date: 15 January 2020Source: Chemical Engineering Journal, Volume 380Author(s): Xiaojuan Zhang, Chuanchuan He, Ruicong Yan, Yan Chen, Pengxuan Zhao, Minsi Li, Ting Fan, Tan Yang, Yao Lu, Jun Luo, Xiang Ma, Guangya XiangAbstractThe clinical efficacy of cisplatin (DDP) treatment is largely limited by cisplatin resistance, which is related to the activation of hypoxia-inducible factor 1 (HIF-1). The HIF-1 activation can be induced by low oxygen availability as well as chemotherapeutics in a reactive oxygen species (ROS) dependent manner. Here, instead of the traditional ROS elevation strategy, we designed a chitos...
Source: Chemical Engineering Journal - Category: Chemistry Source Type: research
The publisher regrets that the Conflict of Interests statements provided by the author were not added as supplementary items. Please see below a summary statement of the conflicts of interest for this manuscript:
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Erratum Source Type: research
i Hong Lee Lung cancer is a type of deadly cancer and a leading cause of cancer associated death worldwide. BCL-2 protein is considered as an imperative target for the treatment of cancer due to their significant involvement in cell survival and death. A carbazole-piperazine hybrid molecule ECPU-0001 was designed and synthesized as a potent BCL-2 targeting agent with effective anticancer cancer activity. Interaction of ECPU-001 has been assessed by docking, molecular dynamics (MD) simulation, and thermal shift assay. Further, in vitro and in vivo anticancer activity was executed by cytotoxicity assay, FACS, colon...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
This study examined the incidence of pathologic N2 non-small-cell lung cancer (NSCLC) and prognostic factors affecting survival in these patients. Methods: A total of 119 patients who underwent surgery for NSCLC (lobectomy, pneumonectomy) between January 2008 and December 2016 were evaluated retrospectively. The patients with pN2 included in the study were assessed in 2 groups; single pN2 and multiple pN2. Results: The most common type of resection was lobectomy (56.3%). Ninety-four patients (79%) received adjuvant therapy. Eighty-six patients (72.3%) had single-station pN2 and 33 (27.7%) had multiple pN2. The 5-year survi...
Source: Acta Chirurgica Belgica - Category: Surgery Tags: Acta Chir Belg Source Type: research
ConclusionThe cellular effects produced by SFN in NSCLC cells are largely mediated by SFN-induced production of ROS. Cells with higher levels of EGFR were more resistant to SFN treatment and showed resistance to SFN-induced apoptosis, suggesting that high EGFR levels protect cells from SFN-induced apoptosis. Despite this, we found that SFN retained the ability to inhibit the growth of NSCLC tumors with high-level EGFR expression in vivo.Graphical abstractModel for the effects of different EGFR expression in SFN-mediated cellular effects.
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
Prophylactic cranial irradiation (PCI) for patients with extensive-stage small-cell lung cancer (ES-SCLC) appears to have become less common in the U.S., according to a new survey.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Conclusions: 3D semiautomatic quantification of PPV is feasible and reproducible using CT in patients with occupational exposure to asbestos. PPV measurement may be useful to correlate with other asbestos-related disease outcomes and prognosis.
Source: Journal of Thoracic Imaging - Category: Radiology Tags: Original Articles Source Type: research
Purpose: A common diagnostic dilemma in the assessment of small pulmonary nodules on computed tomography (CT) is in distinguishing benign intrapulmonary lymph nodes (IPLNs) from small primary pulmonary malignancies. Several CT features have been described of IPLNs, including attachment to a pleural surface. We had observed that IPLNs were often connected to a pulmonary vein and sought to evaluate the utility of this sign in discriminating IPLNs from lung adenocarcinomas. The frequency of other previously described CT signs of IPLNs was also compared with lung adenocarcinomas. Materials and Methods: We retrospectively ...
Source: Journal of Thoracic Imaging - Category: Radiology Tags: Original Articles Source Type: research
Abstract The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interest to identify inhibitors for PD-L1 dimeric structure through molecular docking and virtual screening. The virtual screened compound XGIQBUNWFCCMAS-UHFFFAOYSA-N (PubChem CID: 127263272) displays a high affinity with the target protein. ADMET analysis and cytotoxicity studies further add weight to this compound as a p...
Source: Bioinformation - Category: Bioinformatics Authors: Tags: Bioinformation Source Type: research
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Study